Next, we evaluated the protein expression levels of GPR15L in the lesional skin of humans with representative inflammatory skin diseases, including atopic dermatitis and psoriasis, since the increase in gene expression levels of GPR15L in the lesional skin has been demonstrated in multiple transcriptomic studies in both diseases (10–14, 16–19). The gene discussed is GPR15LG; the disease is inflammatory skin disease.